Crossmark

Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the “Co-MED study”

Crossref DOI link: https://doi.org/10.1186/s13054-018-1955-7

Published Online: 2018-02-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nigro, Nicole http://orcid.org/0000-0003-3251-4121
Winzeler, Bettina

Suter-Widmer, Isabelle

Schuetz, Philipp

Arici, Birsen

Bally, Martina

Refardt, Julie

Betz, Matthias

Gashi, Gani

Urwyler, Sandrine A.

Burget, Lukas

Blum, Claudine A.

Bock, Andreas

Huber, Andreas

Müller, Beat

Christ-Crain, Mirjam
Funding

Funding for this research was provided by:

Universität Basel

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3-123346)
License Information

Text and Data Mining valid from 2018-02-09
More Information

Article History

Received: 9 June 2017

Accepted: 15 January 2018

First Online: 9 February 2018

Ethics approval and consent to participate

: This study was approved by the Ethics Committee of Basel and Aarau. Informed consent was obtained from all patients or their next of kin before enrolment.

: Not applicable.

: PS, BM and MCC have received speaker’s honoraria and research support from Thermo Scientific Biomarkers. The other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.